Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onur Baser

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Advances in Therapy|March 1, 2020
Economic Outcomes in Patients with Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate Plus PrednisoneKrishnan Ramaswamy, Stanislav Lechpammer, Jack Mardekian, et al.
Journal of the American Geriatrics Society|March 31, 2018
Analysis of Episodes of Care in Medicare Beneficiaries Newly Diagnosed with Alzheimer's DiseaseRezaul K Khandker, Christopher M Black, Lin Xie, et al.
Neurology and Therapy|May 17, 2017
A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer's Disease PatientsNawal Bent-Ennakhil, Florence Coste, Lin Xie, et al.
Journal of Medical Economics|March 31, 2016
Comparison of hospital length of stay and hospitalization costs among patients with non-valvular atrial fibrillation treated with apixaban or warfarin: An early viewLin Xie, Lien Vo, Allison Keshishian, et al.
Journal of Alzheimer'S Disease : JAD|November 6, 2017
Economic Burden, Mortality, and Institutionalization in Patients Newly Diagnosed with Alzheimer's DiseaseChristopher M Black, Howard Fillit, Lin Xie, et al.
Current Medical Research and Opinion|June 22, 2017
Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare populationAlpesh Amin, Allison Keshishian, Jeffrey Trocio, et al.
The Journal of Rheumatology|October 17, 2007
The Longitudinal Examination of Arthritis Pain (LEAP) study: relationships between weekly fluctuations in patient-rated joint pain and other health outcomesAdam Hutchings, Michael Calloway, Ernest Choy, et al.
Annals of Surgery|July 13, 2010
Preoperative placement of inferior vena cava filters and outcomes after gastric bypass surgeryNancy J O Birkmeyer, David Share, Onur Baser, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare PopulationAlpesh Amin, Allison Keshishian, Jeffrey Trocio, et al.
Journal of Managed Care & Specialty Pharmacy|April 30, 2020
A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare PopulationAlpesh Amin, Allison Keshishian, Jeffrey Trocio, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Advances in Therapy|March 1, 2020
Economic Outcomes in Patients with Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate Plus PrednisoneKrishnan Ramaswamy, Stanislav Lechpammer, Jack Mardekian, et al.
Journal of the American Geriatrics Society|March 31, 2018
Analysis of Episodes of Care in Medicare Beneficiaries Newly Diagnosed with Alzheimer's DiseaseRezaul K Khandker, Christopher M Black, Lin Xie, et al.
Neurology and Therapy|May 17, 2017
A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer's Disease PatientsNawal Bent-Ennakhil, Florence Coste, Lin Xie, et al.
Journal of Medical Economics|March 31, 2016
Comparison of hospital length of stay and hospitalization costs among patients with non-valvular atrial fibrillation treated with apixaban or warfarin: An early viewLin Xie, Lien Vo, Allison Keshishian, et al.
Journal of Alzheimer'S Disease : JAD|November 6, 2017
Economic Burden, Mortality, and Institutionalization in Patients Newly Diagnosed with Alzheimer's DiseaseChristopher M Black, Howard Fillit, Lin Xie, et al.
Current Medical Research and Opinion|June 22, 2017
Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare populationAlpesh Amin, Allison Keshishian, Jeffrey Trocio, et al.
The Journal of Rheumatology|October 17, 2007
The Longitudinal Examination of Arthritis Pain (LEAP) study: relationships between weekly fluctuations in patient-rated joint pain and other health outcomesAdam Hutchings, Michael Calloway, Ernest Choy, et al.
Annals of Surgery|July 13, 2010
Preoperative placement of inferior vena cava filters and outcomes after gastric bypass surgeryNancy J O Birkmeyer, David Share, Onur Baser, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare PopulationAlpesh Amin, Allison Keshishian, Jeffrey Trocio, et al.
Journal of Managed Care & Specialty Pharmacy|April 30, 2020
A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare PopulationAlpesh Amin, Allison Keshishian, Jeffrey Trocio, et al.
Pageof 16